| __timestamp | Jazz Pharmaceuticals plc | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 406114000 | 1860000 |
| Thursday, January 1, 2015 | 449119000 | 2963000 |
| Friday, January 1, 2016 | 502892000 | 6961000 |
| Sunday, January 1, 2017 | 544156000 | 11779000 |
| Monday, January 1, 2018 | 683530000 | 13697000 |
| Tuesday, January 1, 2019 | 736942000 | 15749000 |
| Wednesday, January 1, 2020 | 854233000 | 18638000 |
| Friday, January 1, 2021 | 1451683000 | 27196000 |
| Saturday, January 1, 2022 | 1416967000 | 31739000 |
| Sunday, January 1, 2023 | 1343105000 | 33491000 |
Unlocking the unknown
In the competitive world of biopharmaceuticals, managing operational costs is crucial. Jazz Pharmaceuticals plc and Protagonist Therapeutics, Inc. offer a fascinating study in contrasts over the past decade. From 2014 to 2023, Jazz Pharmaceuticals saw its Selling, General, and Administrative (SG&A) expenses grow by approximately 230%, peaking in 2021. This reflects their aggressive expansion and investment in market presence. In contrast, Protagonist Therapeutics, Inc., a smaller player, experienced a more modest increase of around 1,700% in the same period, albeit from a much smaller base. This growth underscores their strategic scaling efforts. The data highlights the differing strategies of a well-established firm versus an emerging contender, each navigating the complex landscape of the pharmaceutical industry. As we look to the future, these trends may offer insights into the evolving dynamics of biopharma financial management.
Who Optimizes SG&A Costs Better? Johnson & Johnson or Jazz Pharmaceuticals plc
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Protagonist Therapeutics, Inc.
Sanofi or Jazz Pharmaceuticals plc: Who Manages SG&A Costs Better?
Regeneron Pharmaceuticals, Inc. vs Jazz Pharmaceuticals plc: SG&A Expense Trends
Who Optimizes SG&A Costs Better? GSK plc or Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing argenx SE and Protagonist Therapeutics, Inc.
Selling, General, and Administrative Costs: United Therapeutics Corporation vs Jazz Pharmaceuticals plc
Operational Costs Compared: SG&A Analysis of Neurocrine Biosciences, Inc. and Jazz Pharmaceuticals plc
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Jazz Pharmaceuticals plc
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Celldex Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Opthea Limited and Protagonist Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.